{"name": "AuraSense Therapeutics",
 "permalink": "aurasense-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/aurasense-therapeutics",
 "homepage_url": "http://www.aurasensetherapeutics.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "847.467.2874",
 "description": "",
 "created_at": "Tue Jan 31 02:15:57 UTC 2012",
 "updated_at": "Tue Jan 31 02:15:57 UTC 2012",
 "overview": "\u003Cp\u003EAuraSense Therapeutics, LLC is a privately held biopharmaceutical company founded by Professors Chad A.\nMirkin and C. Shad Thaxton at Northwestern University. The Company is dedicated to developing and commercializing spherical nucleic acid (SNA\u2122) conjugates. Its proprietary SNA constructs possess unparalleled biocompatibility and versatility as therapeutics, and they hold great promise for combating the\nworld\u2019s most threatening diseases. The Company\u0026#8217;s SNA technology overcomes the most difficult obstacles to gene regulation: genetic targeting with safe and effective in vivo performance.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       51],
      "assets/images/resized/0017/2266/172266v1-max-150x150.png"],
     [[250,
       85],
      "assets/images/resized/0017/2266/172266v1-max-250x250.png"],
     [[320,
       110],
      "assets/images/resized/0017/2266/172266v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Founder",
    "person":
     {"first_name": "Chad",
      "last_name": "A. Mirkin",
      "permalink": "chad-a-mirkin",
      "image": null}},
   {"is_past": false,
    "title": "Founder",
    "person":
     {"first_name": "C.",
      "last_name": "Shad Thaxton",
      "permalink": "c-shad-thaxton",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$5.4M",
 "funding_rounds":
  [{"round_code": "b",
    "source_url": "http://onbiovc.com/aurasense-therapeutics-llc-series-b-54m/",
    "source_description": "AuraSense Therapeutics, LLC: Series B $5.4M",
    "raised_amount": 5400000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 12,
    "funded_day": 21,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Abbott Biotech Ventures",
         "permalink": "abbott-biotech-ventures",
         "image":
          {"available_sizes":
            [[[150,
               41],
              "assets/images/resized/0023/2409/232409v3-max-150x150.png"],
             [[250,
               68],
              "assets/images/resized/0023/2409/232409v3-max-250x250.png"],
             [[439,
               120],
              "assets/images/resized/0023/2409/232409v3-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "1801 Maple Avenue",
    "address2": "Suite 4301",
    "zip_code": "60201",
    "city": "Evanston",
    "state_code": "IL",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}